Last reviewed · How we verify

NCT06959485

Oxygen Therapy in Diabetic Kidney Disease

Not yet recruiting NA Last updated 6 May 2025
What this trial tests

NA trial testing Oxygen Therapy in Diabetic Kidney Disease in 80 participants. Not yet recruiting.

Timeline
1 August 2025
Primary endpoint
1 August 2026
10 August 2026

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment80
Start date1 August 2025
Primary completion1 August 2026
Estimated completion10 August 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 10 to 17, any sex, with Diabetic Kidney Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diabetic kidney disease (DKD) is the most significant cause of end-stage kidney disease (ESKD). Albuminuria, evolving from microalbuminuria to nephrotic-range proteinuria, is a clinical hallmark of diabetic nephropathy (DN). It develops in about a third of diabetic patients and is considered an independent risk factor in the progression of DN and for all-cause mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oxygen Therapy

Trials testing the same drug.

Other recruiting trials for Diabetic Kidney Disease

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06959485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing